FDA inspection
Shandong Xinhua Pharmaceuticals (USA) Inc.: FDA inspection ending Jun 2, 2021
FDA inspection 1152172 · No Action Indicated (NAI) · South El Monte, CA
Key facts
| Inspection ID | 1152172 |
|---|---|
| Firm | Shandong Xinhua Pharmaceuticals (USA) Inc. |
| FEI number | 3010034032 |
| Address | 2025 Mountain View Rd |
| City | South El Monte |
| State | CA |
| ZIP | 91733 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Jun 2, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Foodborne Biological Hazards |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data